Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to more accurately assess cardiac function, ventilation and exercise capacity in a non-invasive fashion, and to better characterize exercise intolerance in the setting of three populations of individuals with chronic diseases of childhood (acute lymphoblastic leukemia (ALL), chronic lung disease (CLD) of prematurity, and post-heart transplant (HT))
Physical activity in childhood is an integral part of maintaining health and quality of life. Children who participate in routine physical activity are more likely to maintain a healthy body weight and are less likely to have heart disease, type 2 diabetes and high blood pressure as adults. Children with chronic disease are often limited from full participation in exercise for various reasons -perceived physical limitations, either from the patient and family or from their medical provider, or because of symptoms which cause exercise to feel uncomfortable. As the number of children living and aging with chronic disease continues to grow, the researchers are hoping to expand the current exercise testing capabilities for both clinical care and research in order to (i) provide data to permit formulation of evidence-based guidelines for exercise in chronic childhood disease; (ii) improve understanding of limitations to exercise in this growing population; (iii) learn long-term implications of chronic childhood disease as these individuals enter adulthood.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Case | Adolescent or young adult acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant |
| |
| Control | 14-25 years old healthy individuals who are ambulatory without assistance. We may enroll younger subjects but we wish to subjects to match our patient population |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Physical activity | Other | Participant Reported Physical Activity and Outcomes (completed via REDCap or on paper) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Measure of Peak O2 intake during test exercise | Maximal cardiopulmonary exercise testing (CPX) will be completed on cycle ergometer to determine peak oxygen uptake, a measure of cardiorespiratory fitness | 3-4 hours during the onetime study visit day |
| Measure of Cardiac output during test exercise | Cardiac output is measured using C2H2 open-circuit breathing technique: a mass spectrometer medical gas analyzer will measure gas concentration continuously, yielding serial Stroke Volume measurements during incremental exercise. Cardiac output is the product of heart rate and stroke volume | 3-4 hours during the onetime study visit day |
| Measure | Description | Time Frame |
|---|---|---|
| The proportion of expiratory flow limitation (EFL) | The proportion of expiratory flow limitation (EFL) during exercise while tracking dyspnea and perceived exertion | 3-4 hours during the onetime study visit day |
| Association between cardiac function and patient reported outcomes of perceived fitness |
Not provided
Inclusion Criteria:
Cases:
Controls
Exclusion Criteria:
Cases:
Controls:
Not provided
Not provided
Not provided
The case participants are the ALL survivors, CLD due to prematurity patients, and post-HT recipients. The control participants can be medical students, UMN staff's children, UMN/Fairview staff, medical residents and undergraduate or graduate students. The remaining controls will be from other UMMCH clinics with conditions unlikely to impact exercise capacity such as dermatology, orthopedics or sports medicine and the University Children's Clinic. Approval will be granted from the treating physician before approaching the control participants
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Char Napurski, MPH, CCRP | Contact | 612-626-2140 | bake0257@umn.edu | |
| Pianosi Paolo, MD | Contact | ppianosi@umn.edu |
| Name | Affiliation | Role |
|---|---|---|
| Pianosi Paolo, MD | Masonic Children's Hospital, University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Masonic Cancer Center | Recruiting | Minneapolis | Minnesota | 55455 | United States |
Not provided
Not provided
Not provided
Not provided
Blood sample specimens will be saved for future use investigating biomarkers and/or Blood will be drawn from each participant and then separated and frozen as serum and mononuclear cells. Samples will be stored in the Department of Pediatrics freezers on the University of Minnesota Twin Cities campuses. All samples will be labeled with a unique participant ID number and no personal or identifiable data. Samples will be maintained for up to 5 years. Planned analysis include biomarker assessments. Samples will only be accessible to individuals listed on the IRB approval for this study.
Logistic regression will be used to understand associations between cardiac function and patient reported outcomes of perceived fitness |
| 3-4 hours during the onetime study visit day |
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D007945 | Leukemia, Lymphoid |
| D007938 | Leukemia |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided